findmyKOL
Clinical trialNCT02702271CompletedInterventional

Investigational Device Evaluation of the WATCHMAN FLX™ LAA Closure Technology

SponsorBoston Scientific CorporationEnrollment458Atrial Fibrillation
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

29 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Grandview Medical Center

    Birmingham, Alabama, United States

  • Phoenix Cardiovascular Research Group

    Phoenix, Arizona, United States

  • St. Joseph'S Hospital & Medical Center

    Phoenix, Arizona, United States

  • Nair Research, Llc

    Jonesboro, Arkansas, United States

  • Scripps Green

    La Jolla, California, United States

  • Cedars-Sinai Medical Center

    Los Angeles, California, United States

  • Sharpe Chula Vista Medical Center

    San Diego, California, United States

  • St. John'S Hospital / Pacific Heart

    Santa Monica, California, United States

  • Washington Hospital Center

    Washington D.C., District of Columbia, United States

  • Tallahassee Memorial Hospital

    Tallahassee, Florida, United States

  • Emory University

    Atlanta, Georgia, United States

  • Massachusetts General Hospital

    Boston, Massachusetts, United States

  • Henry Ford Hospital

    Detroit, Michigan, United States

  • Mayo Clinic

    Rochester, Minnesota, United States

  • Healtheast St. Joseph'S Hospital

    Saint Paul, Minnesota, United States

  • Cardiology Associates of N. Mississippi

    Tupelo, Mississippi, United States

  • St. Luke'S Hospital

    Kansas City, Missouri, United States

  • Catholic Medical Center

    Manchester, New Hampshire, United States

  • Cardiovascular Associates of the Delaware Valley

    Sewell, New Jersey, United States

  • Mt. Sinai School of Medicine

    New York, New York, United States

  • New York University Medical Center

    New York, New York, United States

  • Cleveland Clinic

    Cleveland, Ohio, United States

  • Legacy Emanuel Hospital & Health Center

    Portland, Oregon, United States

  • York Hospital

    York, Pennsylvania, United States

  • Vanderbilt University Medical Center

    Nashville, Tennessee, United States

  • Texas Cardiac Arrhythmia

    Austin, Texas, United States

  • Sentara Norfolk General Hospital

    Norfolk, Virginia, United States

  • Virginia Commonwealth University Health System

    Richmond, Virginia, United States

  • Peacehealth Southwest Medical

    Vancouver, Washington, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
7 May 2018
Primary completion
28 Jan 2020
Completion
12 Mar 2021
Last update posted
14 Jun 2022
Registered enrollment
458
Registry id
NCT02702271

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.